NM_001370259.2:c.3G>A
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_001370259.2(MEN1):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001370259.2 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.3G>A | p.Met1? | start_lost | Exon 2 of 10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia, type 1 Pathogenic:5
- -
This sequence change affects the initiator methionine of the MEN1 mRNA. The next in-frame methionine is located at codon 228. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with multiple endocrine neoplasia type 1 (PMID: 28736585, 29036195; internal data). ClinVar contains an entry for this variant (Variation ID: 188376). For these reasons, this variant has been classified as Pathogenic. -
This variant is considered pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 28736585, 35407574, 29036195, 31482957, 36654999, 28329921, 24915123]. -
- -
The c.3G>A, p.Met1? variant identified in the MEN1 gene has been reported previously in individuals affected with MEN1-related disease (PMID:26767918). This variant affects the initiator methionine of the MEN1 mRNA, and the next in-frame methionine is located at codon 228. The variant is absent in the gnomAD v3.1.1 database, indicating it is an extremely rare allele in the populations represented in this database. Other variants that disrupt the initiator methionine in MEN1 also have been observed in affected individuals with MEN1-related disease (PMID: 28736585, 29036195, 15714081, 26515642). Based on the available evidence, the heterozygous start lost variant c.3G>A, p.Met1? in the MEN1 gene is classified as pathogenic. -
not provided Pathogenic:1
Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 26767918) -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.M1? pathogenic mutation (also known as c.3G>A) is located in coding exon 1 of the MEN1 gene and results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon. Since sequence variations that modify the initiation codon (ATG) are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at